Australian Gold

Product NDC
58443-0035
11-digit product format
584430035
Labeler code
58443
Product ID
58443-0035_9c591dec-4d4b-c000-e053-2a95a90a6b67
Type
HUMAN OTC DRUG
Nonproprietary name
Avobenzone, Octisalate, Octocrylene, and Oxybenzone
Dosage form
LOTION
Route
TOPICAL
Labeler
Prime Enterprises, Inc.
Application
part352
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2013-10-14
Marketing end
0000-00-00
Substance
AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE
Active strength
10 mg/mL; mg/mL; mg/mL; mg/mL
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct58443-0035DDiscontinued by firm2026-10-05
excluded packagepackage58443-003558443-0035-4DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage58443-0035-4d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage58443-0035-4f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage58443-0035-42ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage58443-0035-4a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage58443-0035-4cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage58443-0035-4cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage58443-0035-4302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage58443-0035-4ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage58443-0035-40efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage58443-0035-4ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage58443-0035-4367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage58443-0035-4557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOXAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OCTISALATEACTIVE INGREDIENT4X49Y0596WAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WMAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OXYBENZONEACTIVE INGREDIENT95OOS7VE0YAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
AVOBENZONEACTIVE MOIETYG63QQF2NOXAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OCTISALATEACTIVE MOIETY4X49Y0596WAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OCTOCRYLENEACTIVE MOIETY5A68WGF6WMAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OXYBENZONEACTIVE MOIETY95OOS7VE0YAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
.ALPHA.-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L0AUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
3-BUTYLPHTHALIDEINACTIVE INGREDIENT822Q956KGMAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
ALKYL (C12-15) BENZOATEINACTIVE INGREDIENTA9EJ3J61HQAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0XAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
BUTYL ACRYLATE/C16-C20 ALKYL METHACRYLATE/METHACRYLIC ACID/METHYL METHACRYLATE COPOLYMERINACTIVE INGREDIENT7K68DGG29PAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
CARAMELINACTIVE INGREDIENTT9D99G2B1RAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
CARBOMER COPOLYMER TYPE AINACTIVE INGREDIENT71DD5V995LAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1OAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
ISOPROPYLPHTHALIMIDEINACTIVE INGREDIENT1J1MM83329AUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
METHYLISOTHIAZOLINONEINACTIVE INGREDIENT229D0E1QFAAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OLETH-10INACTIVE INGREDIENTJD797EF70JAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
OLIVE OILINACTIVE INGREDIENT6UYK2W1W1EAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
POLYSILICONE-15INACTIVE INGREDIENTF8DRP5BB29AUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3AUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
SORBITAN MONOOLEATEINACTIVE INGREDIENT06XEA2VD56AUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
SUNFLOWER OILINACTIVE INGREDIENT3W1JG795YIAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
TEA TREE OILINACTIVE INGREDIENTVIF565UC2GAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
TRIMETHYLSILOXYSILICATE (M/Q 1.0-1.2)INACTIVE INGREDIENT78GX033D7IAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RAUSTRALIAN GOLD BROAD SPECTRUM SPF 8 (AVOBENZONE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) LOTION [PRIME ENTERPRISES, INC.]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58443-0035-458443003504237 mL in 1 BOTTLE, WITH APPLICATOR (58443-0035-4) 237 ml2013-10-140000-00-00NoNoCurrent